[Remote] GRAIL Galleri Consultant (Clinical Sales - Arizona) #4407 at GRAIL

Arizona, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Reside within the Tucson, AZ Territory (Tucson, AZ, New Mexico, and El Paso, TX)
In-person selling role, spending the majority of time (>85%) making in-person visits to targeted physician practices
Deep understanding of the Laboratory Developed Test (LDT) market, competitive landscape and current cancer screening options

Responsibilities

Be part of a best-in-class commercial organization
Report directly to a GRAIL District Manager
Prospect and target primary care practices in your territory to generate interest in Galleri and identify/onboard early adopter customers
Represent a diverse team of professionals to enhance competitiveness and innovation
Be part of a team and collaborate with internal stakeholders to succeed in creating a new paradigm in cancer screening
Work with executive sales leadership, marketing, customer service, billing, and other customer-facing functions to provide “on the ground” feedback
Develop and implement a business plan to support your territory’s growth
Meet or exceed sales goals by increasing breadth and depth of prescribing, maximize the impact of promotional budgets, and execute the national sales strategy
Identify opportunities in the marketplace, share best practices, and proactively communicate successful selling strategies
Manage implementation of all promotional activities to support sales and marketing strategies
Collaborate with Medical Science Liaisons (MSLs) to educate providers on the science and studies that support MCED technology, and build relationships

Skills

GRAIL

Develops blood tests for early cancer detection

About GRAIL

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$1,765.5MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

Risks

Potential overdiagnosis could impact the perceived value of GRAIL's tests.

Significant net losses may affect investor confidence and long-term sustainability.

High test costs may limit accessibility in markets with less healthcare funding.

Differentiation

GRAIL uses high-intensity sequencing for early cancer detection via blood tests.

The Galleri test screens for over 50 cancers with a single blood draw.

GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Upsides

Collaborations with platforms like Function Health expand Galleri test accessibility.

Revenue from Galleri grew 52% year-over-year, indicating strong market demand.

GRAIL's technology aligns with trends in personalized and preventative medicine.

Land your dream remote job 3x faster with AI

Try Jobo Free